Showing results (291-300 of 303) with videos related to

Sort By:
Pageof 31
The Journal of Infectious Diseases|August 19, 2020
Amylin, Aβ42, and Amyloid in Varicella Zoster Virus Vasculopathy Cerebrospinal Fluid and Infected Vascular CellsAndrew N Bubak, Cheryl Beseler, Christina N Como, et al.
Cancer Research Communications|October 23, 2025
Autologous Thymic Organoids Support Functional T-cell Education and Enhance Antitumor Immunity in Humanized Mice with Melanoma XenograftsJ Jason Morton, Stephan A Ramos, Nathaniel Alzofon, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Inhibition of cell-mediated immunity in type 1 diabetes by beta cell-targeted PD-1 agonists in pancreas tissue slicesMatthew W Becker, Matthew Brown, Katherine Wiseman, et al.
Science Advances|April 1, 2026
Beta cell-targeted PD-1 agonist inhibits cell-mediated autoimmunity in pancreas tissue slicesMatthew W Becker, Matthew E Brown, Katherine Wiseman, et al.
Problemy Endokrinologii|September 17, 2021
[The clinical practice guidelines for primary hyperparathyroidism, short version]N G Mokrysheva, A K Eremkina, S S Mirnaya, et al.
Terapevticheskii Arkhiv|February 20, 2026
[Menopausal hormone therapy in patients with cardiovascular and metabolic diseases: an interdisciplinary Delphi consensus among Russian gynecologists, cardiologists, endocrinologists, gerontologists and geriatricians, phlebologists, and clinical pharmacologists]G T Sukhikh, V N Serov, E V Shlyakhto, et al.
Kardiologiia|December 29, 2025
[Russian Eligibility Criteria for Prescribing Menopausal Hormone Therapy to Patients With Cardiovascular and Metabolic Diseases. Consensus Document of RSC, RSOG, RAE, EUAT, RAP, RSMSI, RAGG]E V Shlyakhto, I I Dedov, V N Serov, et al.
Frontiers in Endocrinology|December 3, 2021
Use of Induced Pluripotent Stem Cells to Build Isogenic Systems and Investigate Type 1 DiabetesLucas H Armitage, Scott E Stimpson, Katherine E Santostefano, et al.
Problemy Endokrinologii|February 5, 2026
[Russian eligibility criteria for prescription of menopausal hormone therapy to patients with cardiovascular and metabolic diseases. Agreement document of RKO, ROAG, RAE, EAT, AFR, RNMOT, RAGG]E V Shlyakhto, I I Dedov, V N Serov, et al.
Nature Reviews. Endocrinology|September 3, 2024
Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road aheadAlessandro Grattoni, Gregory Korbutt, Alice A Tomei, et al.
Pageof 31